Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,67 USD | -6,32% | -10,40% | +11,25% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 51 | 01-01-11 |
David Fang
DFI | Director of Finance/CFO | - | 01-03-18 |
Florian Vogl
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Deanne Miller
COO | Chief Operating Officer | 47 | 17-10-12 |
Frédéric Triebel
CTO | Chief Tech/Sci/R&D Officer | 69 | 12-12-14 |
Claudia Jacoby
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Frank Fliegert
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Russell Howard
CHM | Chairman | 74 | 08-05-13 |
Marc Voigt
CEO | Chief Executive Officer | 51 | 01-01-11 |
Anne Anderson
BRD | Director/Board Member | - | 14/02 |
Frédéric Triebel
CTO | Chief Tech/Sci/R&D Officer | 69 | 12-12-14 |
Pete Meyers
BRD | Director/Board Member | 55 | 12-02-14 |
Lis Boyce
BRD | Director/Board Member | - | 11-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 263 136 719 | 1 224 288 891 ( 96,92 %) | 0 | 96,92 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. |
Biotechnology
|
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |
- Beurs
- Aandelen
- Koers IMM
- Koers IMMP
- Onderneming Immutep ADR